The Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy.

Sun Yat-sen University

Status: Enrolling

Conditions: Esophageal Cancer; Lung Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT06019455

2023-FXY-017

Details and patient eligibility

About

This study aims to assess the level of participation of thoracic cancer patients undergoing definitive radiotherapy and chemotherapy ± immunotherapy in their medical processes and the association between the level of participation and patients' side effects, quality of life, and long-term survival. Additionally, this study will rate the level of participation from both the patients' and medical staff's perspectives and will compare the differences in ratings from these two viewpoints, as well as their impact on treatment outcomes.

Enrollment: 500 estimated patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Locally advanced non-small cell lung cancer, limited-stage small cell lung cancer, and esophageal cancer.
• Planned to undergo definitive chemoradiotherapy ± immunotherapy;
• Males or females aged 18 to 75;
• Able to communicate with medical staff.

Exclusion Criteria: Patients with cognitive impairments.

Trial design

500 participants in 1 patient group

Observational group

Description:

Patients undergoing definitive radiochemotherapy ± immunotherapy will be assessed about the level of participation in their medical processes.